Blue Horseshoe Stocks: Options Review


Options Review

We dedicated yesterday’s premarket newsletters to our Special Report, so we wanted to circle back this morning to go over a couple of options ideas we submitted to our readers on Tuesday morning.

We had identified plays in the ULTA and MKC options chains following a Form-4 Alert and an earnings report, respectively, and in both cases we met with fantastic multi-bag gain opportunities. Here were the total possible profits on the table:

ULTA 11/01 $260-265 Calls
$260 Calls – Range: 4.00-13.30 – Max Gain: 233%
$262.50 Calls – Range: 2.60-12.50 – Max Gain: 381%
$265 Calls – Range: 2.80-11.25 – Max Gain: 302%
_____

MKC Weekly $155-160 Calls

$155 Calls – Range: 5.58-13.58 – Max Gain: 143%
$160 Calls – Range: 2.82-9.12 – Max Gain: 223%
_____

Fresh Options Idea:
PEP Weekly $134-136 Calls 



American Renal Associates Holdings, Inc. ARA

We also want to place ARA on watch as a possible bottom bounce play. The stock has never been much lower than where it’s currently trading, has a recently history of sharp spikes, and indications that a significant rebound could be on the way. We’ll keep an eye peeled for such activity over the next several sessions.


Extended Watchlist:
CBNT, CLVS, ARQL, BIOC, HYRE, MEET

Blue Horseshoe Stocks: Options Trio

Fresh Options Ideas

We have a trio of fresh options ideas for today’s report- a couple of earnings plays, and a Form-4 alert. 

Ulta Beauty, Inc. ULTA – We saw a Form-4 pop up on ULTA last week, as the stock was beginning to find its way up off a bottom. There is an absolutely massive topside gap on the chart, so we’re looking at this as a longer-term idea.

We’re set to track the ULTA 11/01 $260-265 Calls over the next few weeks, which would play very well if the stock can even begin to fill that gap.
_____

McCormick & Co. Inc. MKC – First up for our pair of earnings plays, we’ve got MKC, which posted a Q3 profit beat as well as heightened guidance. We’re going to tag the MKC Weekly $155-160 Calls for observation this morning.
_____

Stitch Fix, Inc. SFIX 
 – Lastly, we’ve got SFIX earns coming up in the post-market this afternoon, and the stock is at a really good spot on the chart. We’re going to radar the SFIX Weekly $19.50-20 Calls.


IMPORTANT REMINDER!

We will be initiating coverage on a brand new high-potential nanotech play tomorrow morning!

Stay glued to those inboxes or visit BlueHorseshoeStocks.com shortly after 9AM tomorrow morning for our Special Report!


Extended Watchlist:
CLSI, ADT, SOL, CFMS, ADXS, IOVA, CVEO

Blue Horseshoe Stocks: SRPT Bottom-Watch

Ulta Beauty, Inc. ULTA

Before we broke for the holiday weekend on Friday, we designated a last minute bearish options idea for ULTA in our premarket report, and thanks to a lackluster day for stocks in general as the markets fell, we saw some nice gains out of those plays, which were the ULTA Weekly $265-260 Puts..

The company also had reported and missed on earnings, receiving multiple analyst downgrades to add fuel to the fire. All of those elements converged to make for the following possible gains for anyone who had caught our alert in the morning.

The $265 Puts traded up from a low of 12.30 and more than doubled as they ran to 26.46 for an intraday move of 115%  The $260’s posted an even bigger gain, running form 7.40-19.90, which worked out to a total possible profit of 169%


Sarepta Therapeutics, Inc. SRPT 

We want to take a look at SRPT as we kick off this short trading week, and form an extended term idea. The stock is heavily oversold at present time as it searches out a bottom, and we would like to be ready and waiting when what we feel is an imminent recovery begins.

There is also a massive topside gap on the SRPT chart that could give the stock even more breathing room when it finally makes its reversal and begins to trend up again. We are going to give ourselves plenty of time on this one, signaling the SRPT 10/04 $91.50-94 Calls to watch in coming weeks.


Extended Watchlist:
VIVE, ARDX, GGAL, TBLT, BNGO, SUPV, TBLT, PGSY